Hero background pattern

We’ll launch your pharmaceuticals to new heights

Specialist and experienced pricing and market access consultancy

Insider Insights

Worldwide: New Coalition to improve access to canc…

According to the UICC, “priority will be given to medicines currently on the WHO Essential Medicin…
Read more
Case Study

With our extensive expertise, we are ideally posit…

We offer comprehensive bespoke market access training solutions, which are tailored to the individua…
Read more

Will the CDF proposals force pharma to prepare for…

Pharma companies must start preparing its NICE submission at the time of making the regulatory subm…
Read more
161 Pharma & biotech companies worked with
11 We work with 11 of the top 20 pharma companies
95% Positive feedback from our training courses
57 We’ve supported pricing and access strategies in 57 countries worldwide

Our Services

From launching your product to access training

Launch Implementation

We will develop and implement a successful launch strategy for your product.

Find out more

Price Optimization

We build payer focussed pricing and market access strategies to enable commercial success.

Find out more

Market Access Training

We provide engaging training solutions that ensures your organisation stays ahead of the ever-changing market access landscape.

Find out more

Our mission

To enable patient access to your products

Unifying our internal strengths and external partnerships helps solve your pricing and market access challenges to drive patient access of your pharmaceutical products.

Our strategy

We have the expertise to get your products into doctors hands

Clearly and concisely communicate key scientific, economic and commercial messages to enable company employees to effectively communicate the product’s value.

How we work

Bespoke approach

Individual solutions to suit you


We adapt our working style to reflect your needs

Real-world pharma experience

We have a wealth of practical knowledge & experience within the pharma industry & HTA bodies


We react quickly and effectively to provide the best support possible

Updates & News

Latest research and publications

Digital health applications in EU5 market access

We explore the rapidly evolving market access landscape in respect to digital health applications in…

Read more
How has the COVID-19 pandemic impacted the use of …

Digital health technology played a vital role during the COVID-19 pandemic as there was a rapid usag…

Read more

We summarise ISPOR Annual 2023 including plenary sessions on artificial intelligence, real-world evi…

Read more
ISPOR US 2023: Plenary Session 2 – AI wants …

Our experts provide a detailed summary of Plenary Session 2 at ISPOR Annual 2023 on artificial intel…

Read more
ISPOR US 2023: Plenary Session 1 – Global Fo…

Our experts provide a detailed summary of Plenary Session 1 at ISPOR Annual 2023 on global affordabi…

Read more
Insider Insights
HAS issues favorable reimbursement opinion

This is the first time that HAS is issuing a favorable opinion for the reimbursement of a technology…

Read more
Insider Insights
NICE collaborates with international partner agenc…

UK, Canada and United States join forces to streamline process and increase transparency for confide…

Read more
Unveiling the Progress of a Coordinated HTA Networ…

We explore the coordinated HTA networks involved in EUnetHTA, define the HTACG and the deliverables …

Read more
Insider Insights
The EU Pharmaceutical package missed the mark in t…

EFPIA and VFA bosses state their concerns that the newly released EU Pharmaceutical Laws will furthe…

Read more
Visit our resource library

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.